Interní Med. 2015; 17(5): 218-222

Therapy of inflammatory bowel disease during pregnancy

MUDr.Jana Koželuhová, MUDr.Karel Balihar, MUDr.Eva Janská, MUDr.Lucie Fremundová, prof.MUDr.Martin Matějovič, Ph.D.
Gastroenterologické a hepatologické oddělení, I. Interní klinika FN a LF v Plzni

Inflammatory bowel diseases (IBD) can affect mainly young people in their reproductive years. IBD therefore has a major impact on

patient’s family planning decisions. Management of IBD in pregnancy requires a challenging balance between optimal disease control

and drug safety. Studies have shown a lack of knowledge among both patients and physicians regarding reproductive issues in IBD. The

aim of this article is to objective review available research data regarding the safety of IBD medication during pregnancy and postpartum

period in women with inflammatory bowel disease.

Keywords: inflammatory bowel disease,Crohn’s disease, ulcerative colitis, pregnancy, breastfeeding, drug treatment

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koželuhová J, Balihar K, Janská E, Fremundová L, Matějovič M. Therapy of inflammatory bowel disease during pregnancy. Interní Med. 2015;17(5):218-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Huang VW, Habal FM. From conception to delivery: managing the pregnant inflammatory bowel disease patient. World J Gastroenterol 2014; 20(13): 3495-3506. Go to original source... Go to PubMed...
    2. Mahadevan U. Pregnancy and inflammatory bowel disease. Med Clin North Am 2010; 94(1): 53-73. Go to original source... Go to PubMed...
    3. van der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010; 4(5): 493-510. Go to original source... Go to PubMed...
    4. Van AG, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De VM, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4(1): 63-101. Go to original source... Go to PubMed...
    5. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JM, Masson PL et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis 2012; 6(8): 811-823. Go to original source... Go to PubMed...
    6. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis 2013; 7(6): e206-e213. Go to original source... Go to PubMed...
    7. Julsgaard M, Norgaard M, Hvas CL, Grosen A, Hasseriis S, Christensen LA. Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease. Scand J Gastroenterol 2014; 49(8): 958-966. Go to original source... Go to PubMed...
    8. Nielsen MJ, Norgaard M, Holland-Fisher P, Christensen LA. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease. Aliment Pharmacol Ther 2010; 32(1): 49-58. Go to original source... Go to PubMed...
    9. Ng SW, Mahadevan U. My treatment approach to management of the pregnant patient with inflammatory bowel disease. Mayo Clin Proc 2014; 89(3): 355-360. Go to original source... Go to PubMed...
    10. Marteau P. IBD and pregnancy. Inflamm Bowel Dis 2008; 14(Suppl 2): S43-S44. Go to original source... Go to PubMed...
    11. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 2008; 25(2): 271-275. Go to original source... Go to PubMed...
    12. Nielsen OH, Maxwell C, Hendel J. IBD medications during pregnancy and lactation. Nat Rev Gastroenterol Hepatol 2014; 11(2): 116-127. Go to original source... Go to PubMed...
    13. Schulze H, Esters P, Dignass A. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation. Aliment Pharmacol Ther 2014; 40(9): 991-1008. Go to original source... Go to PubMed...
    14. Dignass AU, Hartmann F, Sturm A, Stein J. Management of inflammatory bowel diseases during pregnancy. Dig Dis 2009; 27(3): 341-346. Go to original source... Go to PubMed...
    15. Beaulieu DB, Kane S. Inflammatory bowel disease in pregnancy. World J Gastroenterol 2011; 17(22): 2696-2701. Go to original source... Go to PubMed...
    16. Lichtenstein GR, Travis S, Danese S, D'Haens G, Moro L, Jones R et al. Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis. J Crohns Colitis 2015. Go to original source... Go to PubMed...
    17. Peyrin-Biroulet L, Oussalah A, Roblin X, Sparrow MP. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Aliment Pharmacol Ther 2011; 33(6): 707-713. Go to original source... Go to PubMed...
    18. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008; 28(10): 1209-1213. Go to original source... Go to PubMed...
    19. Baumgart DC, Sturm A, Wiedenmann B, Dignass AU. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 2005; 54(12): 1822-1823. Go to original source... Go to PubMed...
    20. Lahiff C, Moss AC. Cyclosporine in the management of severe ulcerative colitis while breast-feeding. Inflamm Bowel Dis 2011; 17(7): E78. Go to original source... Go to PubMed...
    21. Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011; 283(1): 7-18. Go to original source... Go to PubMed...
    22. Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol 2011; 106(2): 214-223. Go to original source... Go to PubMed...
    23. Yarur A, Kane SV. Update on pregnancy and breastfeeding in the era of biologics. Dig Liver Dis 2013; 45(10): 787-794. Go to original source... Go to PubMed...
    24. Zelinkova Z, van der Ent C, Bruin KF, van BO, Vermeulen HG, Smalbraak HJ et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol 2013; 11(3): 318-321. Go to original source... Go to PubMed...
    25. Gisbert JP, Chaparro M. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol 2013; 108(9): 1426-1438. Go to original source... Go to PubMed...
    26. Bortlik M, Duricova D, Machkova N, Kozeluhova J, Kohout P, Hrdlicka L, et al. Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children. Inflamm Bowel Dis 2014; 20(3): 495-501. Go to original source... Go to PubMed...
    27. Zelinkova Z, de HC, de RL, Pierik MJ, Kuipers EJ, Peppelenbosch MP, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther 2011; 33(9): 1053-1058. Go to original source... Go to PubMed...
    28. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11(3): 286-292. Go to original source... Go to PubMed...
    29. Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M et al. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study. Scand J Gastroenterol 2013; 48(8): 951-958. Go to original source... Go to PubMed...
    30. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010; 4(5): 603-605. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.